Literature DB >> 2471999

The importance of CD5-positive B cells in nonorgan-specific autoimmune diseases.

P Youinou1, L Mackenzie, B M Broker, D I Isenberg, A Drogou-Lelong, A Gentric, P M Lydyard.   

Abstract

CD5, the human counterpart of Ly-1 molecules in the mouse, are detectable but weakly expressed on a minute fraction of circulating B cells. The number of CD5-expressing B cells is increased in patients with rheumatoid arthritis or primary Sjögren's syndrome. These cells are similar to those leading to chronic lymphocytic leukemia (they may be induced to produce multispecific autoantibodies). Multispecific autoantibodies have also been described in the early B cell repertoire.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2471999     DOI: 10.3109/03009748809102975

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  5 in total

Review 1.  The B cell system in the rheumatoid inflammation. New insights into the pathogenesis of rheumatoid arthritis using synovial B cell hybridoma clones.

Authors:  J B Natvig; I Randen; K Thompson; O Førre; E Munthe
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Expression of CD22 on peripheral B cells in patients with rheumatoid arthritis: relation to CD5-positive B cells.

Authors:  Yutaka Nakiri; Kentarou Minowa; Jun Suzuki; Akiko Mitsuo; Hirofumi Amano; Shinji Morimoto; Yoshiaki Tokano; Yoshinari Takasaki
Journal:  Clin Rheumatol       Date:  2007-06-22       Impact factor: 2.980

3.  Regulatory B cells and allergic diseases.

Authors:  Geunwoong Noh; Jae Ho Lee
Journal:  Allergy Asthma Immunol Res       Date:  2011-05-30       Impact factor: 5.764

4.  Evidence for somatic selection of natural autoantibodies.

Authors:  T Martin; S F Duffy; D A Carson; T J Kipps
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

5.  Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.

Authors:  Jose Manuel Sánchez-Maldonado; Rafael Cáliz; Miguel Ángel López-Nevot; Antonio José Cabrera-Serrano; Ana Moñiz-Díez; Helena Canhão; Rob Ter Horst; Luca Quartuccio; Signe B Sorensen; Bente Glintborg; Merete L Hetland; Ileana Filipescu; Eva Pérez-Pampin; Pablo Conesa-Zamora; Jerzy Swierkot; Alfons A den Broeder; Salvatore De Vita; Eva Rabing Brix Petersen; Yang Li; Miguel A Ferrer; Alejandro Escudero; Mihai G Netea; Marieke J H Coenen; Vibeke Andersen; João E Fonseca; Manuel Jurado; Katarzyna Bogunia-Kubik; Eduardo Collantes; Juan Sainz
Journal:  Front Immunol       Date:  2021-10-27       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.